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Bioassay-guided fractionation of a cytotoxic extract of 
an Okinawan sponge Plakortis sp. resulted in the 
isolation of a known cyclic peroxide methyl ester (1a) 
along with two new cyclic peroxide acids (1b and 2b) 
and a new aliphatic fatty acid (3).Compound 2b was 
confirmed to be an isomer of 1b by NMR and MS. 
Moreover, careful comparison of the spectroscopic 
data of 2b with that of peroxyplakoric acid A1 methyl 
ester (2a) suggested that compound 2b was identical 
with 2a. Treatment of 2b with TMS diazomethane 
yielded a compound identical with 2a with respect to 
NMR and MS. This data confirmed that the cyclic 
peroxidases 1b and 2b occurred naturally.  
 
Additionally, the structure of 3 was confirmed by 1D 
and 2D NMR experiments. A plausible biosynthetic 
pathway has been proposed that rationalizes 
transformations in the ring-opening of the cyclic 
peroxide. Compound 1a was evaluated to have IC50 8.7 
µg/mL against NBT-T2 cells while compound 3 was 
inactive. This result suggested that the cyclic peroxide 
moiety could be responsible for the cytotoxicity of the 
sponge constituents. 
 
Keywords: Plakortis sp., cyclic peroxide, fatty acid, 1D and 
2D NMR, cytotoxicity. 
 
Introduction 
The sponge of the genus Plakortis is well known as a prolific 
source of biologically active secondary metabolites.1 Cyclic 
peroxides with different side chains are frequently isolated 
from this genus of sponge and have been reported to have 
antifungal9, antimalarial2, antimicrobial13 and antitumor5 
activity. The sponge is well known as a source of peroxy 
ring-containing compounds plakortin10  along with the cyclic 
peroxide containing the unsaturated side chain and methyl 
ester form6. In search of new biologically active molecules 
from marine organisms, we have isolated three cyclic 
peroxides (1a, 1b and 2b) and a fatty acid (3) from a marine 
sponge Plakortis sp. collected off Irabu Island, Okinawa. In 
particular, compounds 1a, 1b and 2b contained the identical 
side chain, but the substituents and configurations on a 1,2-
dioxane ring were dissimilar between the three compounds. 
 
Herein, we describe the isolation and stereo structural 
characterization of the isolated compounds together with 
their biological activities. The antifungal structure-activity 
relationships of the cyclic peroxides (1−3) and the 
rearrangement product (1b) were evaluated for its 
cytotoxicity against rat bladder tumor cells NBT-T2. 
 
Material and Methods 
General: 1H, 13C and 2D NMR (COSY, HSQC and HMBC) 
spectra were obtained on a Bruker Avance III 500 NMR 
spectrometer in CDCl3 with reference to an internal standard 
of TMS. Chemical shifts and coupling constants were given 
as  and Hz. FTIR spectrum was taken on a Varian FTS-3000 
instrument. HRESIMS measurements were performed on a 
Jeol JMS-T 100LP mass spectrometer and the molecular 
formulas were analyzed using a program Mass Center 
(Version 1.3.10, MS_56010 MP). Purification was done with 
Hitachi or Shimadzu HPLC instruments using Cosmosil 
(Nacalai) or Mightysil (Wako) columns. 
 
Animal materials: The sponge Plakortis sp. was collected 
off Irabu Island in Okinawa by using SCUBA diving and 
kept frozen until extraction with code MJ-JT-12-560. 
 
Extraction and Isolation: The collected specimen was 
extracted with acetone (500 mL) three times. After solvent 
removal using rotary evaporation, the extract was partitioned 
between EtOAc and water. The EtOAc layer was 
concentrated to give the lipophilic fraction and the aqueous 
layer was dissolved in MeOH to give the more polar fraction. 
The fractions were tested for their cytotoxicity against NBT-
T2 cells (at 10 and 100 µg/mL). The active EtOAc extract 
(372.5 mg) was separated using silica gel column 
chromatography with eluents: n-hexane:EtOAc (4:1, 3:1, 
2:1), CH2Cl2, EtOAc and EtOAc:MeOH (1:1) to give six 
fractions.  
 
The second fraction (16.9 mg) was further separated by 
using normal phase HPLC with n-hexane: EtOAc mixture as 
an eluent furnished 13 fractions. The fifth faction (9.3 mg) 
was purified to give compound 1a (2.4 mg) by using 
reversed phase HPLC with MeOH: H2O (7:3) as a solvent 
system. The EtOAc fraction (18.1 mg) was subjected to 
normal phase HPLC using n-hexane: EtOAc (1:1) as the 
solvent system, this yielded compounds 1b and 2b.  
 
The CH2Cl2 (15.8 mg) fraction was subjected to normal 
phase HPLC resulting in five fractions. The third fraction 
from this was separated by using PTLC with once elution to 
give compound 3 (1.1 mg). 
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Methylation of compound 2b: Excess TMSCHN2 was 
added to a solution of compound 2b (0.1 mg) dissolved in 
MeOH (100 µL). The reaction was monitored by TLC. After 
an hour, the solution was concentrated under nitrogen flow. 
 
Cytotoxic Assay: NBT-T2 cells derived from chemically 
induced rat bladder carcinoma cells were used in screening 
and evaluating the cytotoxic activity7. NBT-T2 cells (Riken 
Bio Resource Center) cultured in Dulbecco’s Modified 
Eagle’s Medium (DMEM) were incubated at 37oC under 5% 
CO2 in a 96 well plate (100 µL each). After 24 hours, the 
cells were exposed to graded concentrations of tested 
compounds and then were placed in an incubator at 37oC.  
 
After 48 hours, the cells were treated with 100 µL of 0.02% 
MTT solution (incubated for 3 hours at 37oC). After removal 
of the solution, residual formazan was dissolved in 100 µL 
of DMSO. The absorbance was measured on a microplate 
reader at 575 nm and the IC50 value was calculated by using 
a software Kaleidagraph. 
 
Results and Discussion 
In this study, we report the isolation of peroxyketal 
metabolites from a sponge Plakortis sp. collected off Irabu 
Island, Okinawa including their activity. Marine sponges 
belonging to the family Plakinidae have been known as a 
vast source of natural products particularly for their peroxide 
and peroxide-derived compounds4,5. 
 
Compound 1a was isolated as a colorless oil (2.4 mg). It 
showed a pseudo-molecular ion at m/z 363.21429 [M+Na]+ 
in the positive HRESIMS corresponding to the molecular 
formula C19H32O5 with four degrees of unsaturation. The 1H 
NMR spectrum of compound 1a showed a methyl triplet (δ 
0.98, J = 7.5 Hz), a methyl doublet (δ 1.41, J = 7.0 Hz) and 
a methyl singlet on a double bond (δ 1.71). Of two methoxy 
singlets (δ 3.27 and 3.72), the latter one is suspected to be 
from a carbomethoxy group. Three olefinic protons appeared 
as a triplet (δ 5.38, J = 7.0 Hz) and a doublet (δ 6.06, J = 15.5 
Hz) and a multiplet (δ 5.51).  
 
In the 13C NMR spectrum, two signals at δ 80.5 and 104.6 
may suggest the presence of an endoperoxide group. Based 
on the HRESIMS and NMR data, compound 1a was 
determined to be the antifungal compound peroxyplakoric 
acid B1 methyl ester12 (Figure 1). 
 
Compound 2b (1.4 mg) was obtained along with compound 
1b (10.5 mg). Both compounds showed similarities in their 
1H NMR spectra to that of compound 1a except the absence 
of a carbomethoxy signal. HRESIMS data of the pseudo-
molecular ion for compound 2b at m/z 349.20188 [M+Na]+ 
indicated the loss of 14 mass units from compound 1a 
suggesting the presence of a carboxylic acid instead of a 
methyl ester. The mass data of compound 1b at m/z 
349.19687 [M+Na]+ indicated that this compound also has a 
carboxylic acid moiety. Comparison of the NMR data of 2b 
with those of 1a and 1b, the difference is expected at C-2 
and/or C-3 positions due to the chemical shifts of H-2 (δ 
2.56), H-2Me (δ 1.26) and H-3 (δ 4.26).  
 
NMR data of compound 2b was similar to that of a known 
compound peroxyplakoric acid A1 methyl ester (2a)4. 
Furthermore, methylation of 2b with TMS diazomethane 
yielded 2a which showed a carboxyl methyl at δ 3.70 on the 
1H NMR spectrum and a mass peak at m/z 363.21366 
[M+Na]+. This treatment confirmed that the free acid 
compound 2b is naturally occurring and it is possible to turn 
2b into the methyl ester compound 2a during the isolation 
process. The comparison of 1H and 13C NMR data for the 
compounds was tabulated as shown in tables 1 and 2. 
 
Compound 1a showed cytotoxicity against NBT-T2 cells 
with IC50 8.7 µg/m. Compounds 1b, 2a and 2b did not show 
activity in the cytotoxicity test due to the decomposition 
process during the assay as it was confirmed by the NMR 
measurements displaying a mess spectrum totally. Although 
the cyclic peroxide group was reported to be stable, there 
might be a condition that leads to a degradation process. The 
presence of methoxy group in structure 1a is essential for the 
bioactivity. Furthermore, the stereochemistry in C-2 has a 
great effect in the cytotoxicity.  Schirmeister et al16 reported 
the effect of stereochemistry related to presence or absence 
of the methyl group on the cytotoxicity of endoperoxide.  
Plakortides, the peroxy compounds isolated from the sponge 
Plakortis angulospiculatus were reported active against 
some cancer cell line15. 
 
Compound 3 was isolated as an oil. The molecular formula 
C11H18O2 was deduced by negative mode HRESIMS of m/z 
181.12285 [M+H]- and 13C NMR which required three 
degrees of unsaturation. Three olefinic signals at δ 6.08 (d, 
J=15.5), 5.50 (m) and 5.38 (brt, J=7.0), a methyl singlet at δ 
1.71 and a methyl triplet at δ 0.98 (J=7.5 Hz) in the 1H NMR 
spectrum of 5 (Figure 5) represented typical signals to those 
of cyclic peroxides side chains as shown in 
Manadoperoxide13.  
 
The lack of seven carbons signals in the 13C NMR data, when 
compared to the peroxyplakoric acids, indicated the absence 
of a cyclic peroxide along with the methoxy and secondary 
methyl portions. In addition, a carboxy signal at δ 177.7 in 
the 13C NMR spectrum exhibited the presence of carboxylic 
acid functionality in the structure. The use of 1D and 2D 
(COSY and HMBC) NMR including decoupling 
observations allowed for the conclusion that compound 3 is 
a new aliphatic unsaturated fatty acid structure as shown in 
figure 2. 
 
Compound 3 could be a degradation product of cyclic 
peroxide compounds. The cyclic peroxide moiety might be 
decomposed through a reduction process to form a diol 
moiety and give a hemiketal moiety14. The hemiketal could 
then turn into a ketone functionality and become an ester 
through Baeyer-Villiger oxidation16. 
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Table 1 
1H NMR data for compounds 1a, 1b, 2a and 2b (500 MHz, CDCl3, J in Hz) 
 
Position 1a 2b 1b 2a 
2 3.06 dq (9.5, 7.0) 2.56 m 3.07 dq (7.0, 7.0) 2.51 dq (7.5, 7.5) 
3 4.20 dt (9.5, 6) 4.24 m 4.20 ddd (10, 6.0, 6.0) 4.19 m 
4 1.43 m 1.50 m 1.42 m 1.52 m 
5 1.68 m 1.91 m 1.67 m 1.90 m 
7 1.63 m 1.62 m 1.63 m 1.63 m, 1.68 m 
8 1.42 m 1.43 m 1.42 m 1.35 m, 1.45 m 
9 2.10 m 2.10 m 2.10 m 2.10 m 
10 5.51 m 5.51 m 5.51 m 5.51 m 
11 6.06 (15.5) 6.05 d (15.5) 6.06 d (15.5) 6.05 d (15.5) 
13 5.38 t(7.0) 5.37 t (7.0) 5.38 t (7.0) 5.37 t (7.0) 
14 2.15 m 2.11 m 2.15 m 2.15 m 
15 0.98 t (7.5) 0.98 t (7.5) 0.98 t (7.5) 0.98 t (7.5) 
16 1.14 d (7.0) 1.26 d (7.0) 1.14 d (7.0) 1.25 d (7.0) 
17 1.71 s 1.71 s 1.71 s 1.71 s 
OCH3 3.72 s - - 3.70 s 
OCH3 3.27 3.26 s 3.27 s 3.26 s 
 
Table 2 
13C NMR data for compounds 1a, 1b and 2b (500 MHz, CDCl3) 
 
Position 1a 1b 2b 
1 175.1 n.o. 179.5 
2 41.7 43.0 41.4 
3 80.7 80.7 80.5 
4 20.4 23.0 20.3 
5 26.6 30.4 26.5 
6 104.6 102.9 104.6 
7 31.0 32.1 31.1 
8 22.9 22.9 22.9 
9 32.8 32.8 32.8 
10 126.3 126.3 126.2 
11 135.7 135.6 135.7 
12 132.8 132.7 132.8 
13 132.8 132.8 132.8 
14 21.4 21.4 21.4 
15 14.1 14.1 14.1 
16 13.8 12.8 13.7 
17 12.3 12.3 12.3 
1’ 51.9 - - 
6’ 48.9 48.5 48.9 
               n.o: not observed 
 
Research Journal of Biotechnology                                                                                                               Vol. 14 (7) July (2019)  



















R= H     (2b)  
Figure 1: The compounds isolated from the sponge Plakortis sp. collected from Okinawa water. 
 
To confirm this hypothesis, follow up experiments would 
need to be done. The ester was then hydrolyzed to an acid 
group (Scheme 1). Compound 3 was not active in the 
cytotoxicity test toward NBT-T2 cells. Our previous 
research showed, some compounds from marine sponges 
showed activity against the NBT-T2 cells17.  Other study 
exhibited that halioxepine inhibited the cell line at 4.8 
µg/mL17 and other compounds, biaketide and debromo-











The investigation of bioactive compounds derived from an 
Okinawan sponge Plakortis sp. revealed cyclic peroxides 
methyl ester (1a), two new cyclic peroxide acids (1b and 2b) 
and a fatty acid (3). Compound 1a was active in the 
cytotoxicity test with IC50 8.7 µg/mL against NBT-T2 cells.  
 
Compound 3 may arise from a base-promoted rearrangement 
of cyclic peroxide containing the compound. This could 
occur from a reduction process led by the ring-opening and 
the acid being formed via Baeyer-Villiger oxidation. This 
compound has no cytotoxic property which may be due to 






















Scheme 3: Plausible degradation mechanism of 
peroxyplakoric acids into compound 3 
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